Compare NICE & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NICE | MMED |
|---|---|---|
| Founded | 1986 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.5B |
| IPO Year | 1999 | 2025 |
| Metric | NICE | MMED |
|---|---|---|
| Price | $116.94 | $19.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $132.77 | $24.85 |
| AVG Volume (30 Days) | 504.4K | ★ 5.3M |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $3,102,000,000.00 |
| Revenue This Year | $8.03 | $10.81 |
| Revenue Next Year | $9.06 | $8.28 |
| P/E Ratio | $11.21 | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $83.10 | $10.65 |
| 52 Week High | $138.58 | $24.43 |
| Indicator | NICE | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 59.96 | 43.37 |
| Support Level | $96.03 | $10.68 |
| Resistance Level | $119.25 | $20.88 |
| Average True Range (ATR) | 4.64 | 0.72 |
| MACD | 0.24 | -0.17 |
| Stochastic Oscillator | 48.23 | 25.50 |
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.